|
1）細菌性髄膜炎の診療ガイドライン作成委員会．細菌性髄膜炎の診療ガイドライン2006年
|
|
|
|
|
2）川崎幸彦，細矢光亮，永井真紀，他．福島県下における小児細菌性髄膜炎103例の疫学的臨床的検討．日児誌．2000; 104: 938-45
|
|
|
|
|
3）細矢光亮，松本歩美．経口抗菌薬と薬剤耐性化—細菌性髄膜炎から子どもたちを守るために—．小児科臨床．2009; 62: 173-8
|
|
|
|
|
|
4）Quagliarello V, Scheld WM. Bacterial meningitis: pathogenesis, pathophysiology, and progress. N Engl J Med. 1992; 327: 864-72
|
|
|
|
|
5）Tunkel AR, Hartman BJ, Kaplan SL, et al. Practice Guidelines for the management of bacterial meningitis. Clin Infect Dis. 2004; 39: 1267-84
|
|
|
|
|
|
6）Centers for Disease Control and Prevention (CDC). Progress toward elimination of Haemophilus influenzae type b disease among infants and children-United States, 1987-1995. MMWR Morb Mortal Wkly Rep. 1996; 45: 901-6
|
|
|
|
|
|
7）Centers for Disease Control and Prevention (CDC). Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease-United States, 1998-2003. MMWR Morb Mortal Wkly Rep. 2005; 54: 893-7
|
|
|
|
|
|
8）庵原俊昭，管 秀，浅田和豊，他．インフルエンザ菌b型(Hib)ワクチンおよび7価肺 炎球菌結合型ワクチン(PCV7)導入が侵襲性細菌感染症に及ぼす効果について．IASR. 2012; 33: 71-2
|
|
|
|
|
|
9）新庄正宣，岩田 敏，佐藤吉壮，他．本邦における小児細菌性髄膜炎の動向（2009-2010）．感染症学雑誌．2010; 86: 582-91
|
|
|
|
|
10）Chiba N, Morozumi M, Sunaoshi K, et al. IPD Surveillance Study Group: Serotype and anti-biotic resistance of isolates from patients with invasive pneumococcal disease in Japan. Epidemiol Infect. 2010; 138: 61-8
|
|
|
|
|
|
11）生方公子．わが国における侵襲性感染症由来インフルエンザ菌の薬剤耐性化動向．IASR. 2010; 31: 98-9
|
|
|
|
|
|
12）岩田 敏．小児重症細菌感染症の治療戦略．小児科臨床．2012; 6: 2434-43
|
|
|
|
|
|
13）Curtis S, Stobart K, Vandermeer B, et al. Clinical features suggestive of meningitis in children: a systematic review of prospective data. Pediatrics. 2010; 126: 952-60
|
|
|
|
|
|
14）de Jonge RC, van Furth AM, Wassenaar M, et al. Predicting sequelae and death after bacterial meningitis in childhood: a systematic review of prognostic studies. BMC Infect Dis. 2010; 10: 232
|
|
|
|
|
|
15）Ozen M, Kanra G, Kara A, et al. Long-term effects of dexamethasone on hearing ability in children with pneumococcal meningitis. Turk J Pediatr. 2008; 50: 23-9
|
|
|
|
|
|
16）Peltola H, Roine I, Fernández J, et al. Hearing impairment in childhood bacterial meningitis is little relieved by dexamethasone or glycerol. Pediatrics. 2010; 125: e1-8
|
|
|
|
|
|
17）Airede KI, Adeyemi O, Ibrahim T. Neonatal bacterial meningitis and dexamethasone adjunctive usage in Nigeria. Niger J Clin Pract. 2008; 11: 235-45
|
|
|
|
|